406 – Chronic Hbv Patients Who Switched to Tenofovir Alafenamide (TAF) After Either 2 Or 3 Years of Prior Tenofovir Disoproxil Fumarate (TDF) Treatment Demonstrated Improvement in Bone and Renal Safety
作者
Marı́a Buti,Namiki Izumi,Young‐Suk Lim,Harry L.A. Janssen,Jia‐Horng Kao,Adrian Streinu‐Cercel,Нурмухаметова Елена Андреевна,Xiaoli Ma,Omer Tabak,Maciej Jabłkowski,Vithika Suri,John F. Flaherty,Audrey H. Lau,Anuj Gaggar,Shuyuan Mo,Abhijit Chowdhury,Scott K. Fung,Wan‐Long Chuang,Edward John Gane